On 29 February, In an oral presentation at the New York Academy of Sciences’ Emerging Approaches to Cancer Immunotherapy conference, John Hunter, Ph.D., Site Head and Vice President of Antibody R&D at Compugen USA, Inc., a wholly owned subsidiary of Compugen Ltd. (NASDAQ:CGEN), presented results for CGEN-15029, the lead internal program in the Company’s immuno-oncology therapeutics pipeline. CGEN-15029 is one of the multiple novel immune checkpoint target candidates discovered by the Company through the use of its unique in silico predictive discovery capabilities.
Compugen Ltd. (NASDAQ:CGEN) belongs to Healthcare sector. Its weekly performance is 14.55%. On last trading day company shares ended up at $5.51.
Cott Corporation (NYSE: COT) announced that it has entered into an agreement pursuant to which a syndicate of underwriters co-led by CIBC Capital Markets Inc. (“CIBC”) and Barclays Capital Canada Inc. (“Barclays”), has agreed to purchase, on a bought deal basis, 11,100,000 common shares (12,765,000 common shares if the over-allotment described below is exercised in full) at a price of US$11.80 per share for gross proceeds to Cott of approximately US$131 million (US$151 million if the over-allotment option is exercised in full).
Cott Corporation (NYSE:COT) shares fell -2.38% in last trading session and ended the day at $12.29. COT Gross Margin is 30.40% and its return on assets is -0.10%. Cott Corporation (NYSE:COT) quarterly performance is 17.50%.
Speedway Motorsports, Inc. (NYSE:TRK), a leading marketer, promoter and sponsor of motorsports entertainment, will host its quarterly conference call on Wednesday, March 9, 2016 at 10:00 a.m. (ET).
On 02 March, Speedway Motorsports Inc. (NYSE:TRK) shares moved up 1.52% and was closed at $18.71. TRK EPS growth in last 5 year was 44.80%. Speedway Motorsports Inc. (NYSE:TRK) year to date (YTD) performance is -8.96%.
Actions Semiconductor Co., Ltd. (NASDAQ:ACTS) ended the last trading day at $1.39. Company weekly volatility is calculated as 1.45% and price to cash ratio as 0.59. Actions Semiconductor Co., Ltd. (NASDAQ:ACTS) showed a weekly performance of 0.77%.
On 25 February, La Jolla Pharmaceutical Co. (NASDAQ:LJPC) had $126.5 million in cash and cash equivalents, compared to $48.6 million as of December 31, 2014. The increase in cash and cash equivalents was primarily due to cash provided by our common stock offering that was completed in September 2015, which was partially offset by net cash used for operating activities. Based on current operating plans and projections, La Jolla believes that its current cash and cash equivalents are sufficient to fund operations into 2018.
La Jolla Pharmaceutical Co. (NASDAQ:LJPC) shares moved up 9.81% in last trading session and ended the day at $18.81. LJPC return on assets is -54.30%. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) quarterly performance is -44.33%.